Naomi Hasegawa
Overview
Explore the profile of Naomi Hasegawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yasuda Y, Ito S, Matsumoto J, Okada N, Onitsuka T, Ikeda M, et al.
Neuropsychopharmacol Rep
. 2025 Feb;
45(1):e70010.
PMID: 40011069
One of the challenges in diagnosing psychiatric disorders is that the results of biological and neuroscience research are not reflected in the diagnostic criteria. Thus, data-driven analyses incorporating biological and...
2.
Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With Schizophrenia
Ito S, Sumiyoshi C, Matsumoto J, Miura K, Yasuda Y, Hasegawa N, et al.
Neuropsychopharmacol Rep
. 2025 Feb;
45(1):1-6.
PMID: 39936235
Schizophrenia causes cognitive dysfunction. The assessment of cognitive function is important in the treatment of schizophrenia. The Wechsler Adult Intelligence Scale (WAIS) is used to assess cognitive function in patients...
3.
Ochi S, Tsuboi T, Hasegawa N, Hori H, Ichihashi K, Imamura Y, et al.
Neuropsychopharmacol Rep
. 2024 Nov;
45(1):e12499.
PMID: 39509554
Aim: Constipation is one of the most common adverse effects in schizophrenia treatment, and it can sometimes cause severe gastrointestinal disease. However, the results of association studies between constipation and...
4.
Furuichi M, Kawaguchi T, Pust M, Yasuma-Mitobe K, Plichta D, Hasegawa N, et al.
Nature
. 2024 Sep;
633(8031):878-886.
PMID: 39294375
Persistent colonization and outgrowth of potentially pathogenic organisms in the intestine can result from long-term antibiotic use or inflammatory conditions, and may perpetuate dysregulated immunity and tissue damage. Gram-negative Enterobacteriaceae...
5.
Matsumoto J, Ito S, Yamazaki R, Nemoto K, Fukunaga M, Kodaka F, et al.
PCN Rep
. 2024 Jun;
2(2):e108.
PMID: 38868134
No abstract available.
6.
Tran K, Schefler A, Chevli N, Hasegawa N, Ivey F, Olek D, et al.
Brachytherapy
. 2024 Jun;
23(5):604-609.
PMID: 38851918
Purpose: Eye plaque brachytherapy (EPBT) is the most common treatment for uveal melanoma with high local control rates of 95-100%. When local recurrences occur following EPBT, salvage options include enucleation,...
7.
Morita K, Miura K, Toyomaki A, Makinodan M, Ohi K, Hashimoto N, et al.
JMIR Ment Health
. 2024 May;
11:e56668.
PMID: 38815257
Background: Schizophrenia is a complex mental disorder characterized by significant cognitive and neurobiological alterations. Impairments in cognitive function and eye movement have been known to be promising biomarkers for schizophrenia....
8.
Nakamura T, Furihata R, Hasegawa N, Kodaka F, Muraoka H, Ichihashi K, et al.
BMC Psychiatry
. 2024 May;
24(1):399.
PMID: 38807065
Background: To examine whether the "Effectiveness of Guideline for Dissemination and Education in psychiatric treatment (EGIUDE)" project affects the rate of prescriptions of hypnotic medication and the type of hypnotic...
9.
Yamazaki R, Matsumoto J, Ito S, Nemoto K, Fukunaga M, Hashimoto N, et al.
Neuropsychopharmacol Rep
. 2024 Feb;
44(1):206-215.
PMID: 38348613
Establishing a brain biomarker for schizophrenia is strongly desirable not only to support diagnosis by psychiatrists but also to help track the progressive changes in the brain over the course...
10.
Hasegawa N, Teh B, Tran K, Ivey F, Olek D, Pino R, et al.
Am J Ophthalmol
. 2023 Dec;
260:49-59.
PMID: 38081570
Purpose: To associate clinical factors and radiation doses delivered by iodine-125 plaque brachytherapy to visual outcomes and development of radiation-induced ocular complications in patients with uveal melanoma in the era...